GRDN Guardian Pharmacy Services, Inc.
Healthcare$38.59+0.29%ClosedMarket Cap: $2.44B
As of 2026-05-26
Valuation
P/E (TTM)
50.38
PEG
0.32
P/B
11.03
P/S
1.67
EV/EBITDA
22.57
DCF Value
$27.78
FCF Yield
2.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
20.9%
Operating Margin
5.7%
Net Margin
3.6%
ROE
27.2%
ROA
12.4%
ROIC
20.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $336.6M | 22.7% | $17.7M | $13.3M | $— | — |
| Q4 null | $397.6M | 21.5% | $36.6M | $20.9M | $— | — |
| FY null | $1.45B | 19.5% | $88.9M | $49.2M | $— | — |
| Q3 null | $377.4M | 19.8% | $16.8M | $9.8M | $— | — |
| Q2 null | $344.3M | 19.8% | $12.6M | $9.0M | $— | — |
| Q1 null | $329.3M | 19.5% | $13.0M | $9.4M | $— | — |
| Q4 null | $338.6M | 19.8% | $16.8M | $11.9M | $— | — |
| FY null | $1.23B | 19.9% | $-62.9M | $-87.3M | $— | — |
| Q3 null | $314.4M | 19.4% | $-104.6M | $-112.6M | $— | — |
| Q2 null | $300.0M | 20.4% | $17.0M | $10.6M | $— | — |
| Q1 null | $275.4M | 20.0% | $7.9M | $2.8M | $— | — |
| Q4 2023 | $281.1M | 19.4% | $15.5M | $12.0M | $0.38 | — |